title: Acute generalized exanthematous pustulosis in a patient receiving high-dose recombinant interleukin-2.
authors.affiliation: Department of Dermatology, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
authors.forename: Nilanthi D
authors.initials: ND
authors.lastname: Gunawardane
authors.forename: Sapna P
authors.initials: SP
authors.lastname: Vaghani
authors.forename: Timothy M
authors.initials: TM
authors.lastname: Kuzel
authors.forename: Jonathan A
authors.initials: JA
authors.lastname: Cotliar
mesh_terms: D056150:Acute Generalized Exanthematous Pustulosis / Q000209:etiology* / Q000473:pathology*; D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001707:Biopsy, Needle; D002292:Carcinoma, Renal Cell / Q000188:drug therapy / Q000473:pathology; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D006801:Humans; D007150:Immunohistochemistry; D007376:Interleukin-2 / Q000009:adverse effects* / Q000627:therapeutic use; D007680:Kidney Neoplasms / Q000188:drug therapy / Q000473:pathology; D008297:Male; D018570:Risk Assessment; D012720:Severity of Illness Index
chemical_list: D000970:Antineoplastic Agents; D007376:Interleukin-2